- Home
- NXGL vs IRIX Comparison
NXGL vs IRIX Comparison
Compare NXGL & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- IRIX
- Stock Information
- Founded
- NXGL 1997
- IRIX 1989
- Country
- NXGL United States
- IRIX United States
- Employees
- NXGL N/A
- IRIX N/A
- Industry
- NXGL Medical/Dental Instruments
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NXGL Health Care
- IRIX Health Care
- Exchange
- NXGL Nasdaq
- IRIX Nasdaq
- Market Cap
- NXGL 19.7M
- IRIX 16.5M
- IPO Year
- NXGL 2021
- IRIX 1996
- Fundamental
- Price
- NXGL $2.65
- IRIX $0.92
- Analyst Decision
- NXGL
- IRIX
- Analyst Count
- NXGL 0
- IRIX 0
- Target Price
- NXGL N/A
- IRIX N/A
- AVG Volume (30 Days)
- NXGL 41.5K
- IRIX 68.3K
- Earning Date
- NXGL 08-13-2025
- IRIX 08-07-2025
- Dividend Yield
- NXGL N/A
- IRIX N/A
- EPS Growth
- NXGL N/A
- IRIX N/A
- EPS
- NXGL N/A
- IRIX N/A
- Revenue
- NXGL $10,228,000.00
- IRIX $48,804,000.00
- Revenue This Year
- NXGL $52.35
- IRIX $9.61
- Revenue Next Year
- NXGL $42.38
- IRIX N/A
- P/E Ratio
- NXGL N/A
- IRIX N/A
- Revenue Growth
- NXGL 116.01
- IRIX N/A
- 52 Week Low
- NXGL $1.95
- IRIX $0.78
- 52 Week High
- NXGL $5.10
- IRIX $2.41
- Technical
- Relative Strength Index (RSI)
- NXGL 60.17
- IRIX 46.02
- Support Level
- NXGL $2.31
- IRIX $0.87
- Resistance Level
- NXGL $2.78
- IRIX $1.00
- Average True Range (ATR)
- NXGL 0.20
- IRIX 0.04
- MACD
- NXGL 0.04
- IRIX 0.00
- Stochastic Oscillator
- NXGL 74.53
- IRIX 46.15
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.